Mabpharm Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	109.26	89.34	173.35	33.57	81.56
Trading Asset Securities	-	-	-	15.04	-
Cash & Short-Term Investments	109.26	89.34	173.35	48.61	81.56
Cash Growth	22.29%	-48.46%	256.59%	-40.39%	-83.18%
Accounts Receivable	155.06	94.53	19.42	9.53	0.79
Other Receivables	-	9.2	23.97	30.66	41.47
Receivables	155.06	103.73	43.39	40.2	42.27
Inventory	136.56	111.01	102.04	100.8	53.21
Restricted Cash	-	39.34	-	-	-
Other Current Assets	33.42	22.35	23.43	11.52	70.74
Total Current Assets	434.3	365.77	342.21	201.12	247.77
Property, Plant & Equipment	568.99	614.25	686.54	704.01	561.05
Other Intangible Assets	96.26	-	-	-	-
Long-Term Deferred Tax Assets	52.97	-	-	-	-
Long-Term Deferred Charges	-	33.35	-	-	-
Other Long-Term Assets	0.94	2.85	6.23	12.39	91.09
Total Assets	1,153	1,016	1,035	917.52	899.9
Accounts Payable	243.93	11.71	10.03	16.77	60.09
Accrued Expenses	-	36.1	47.25	54.73	57.9
Short-Term Debt	-	-	-	-	0.74
Current Portion of Long-Term Debt	210.13	80.05	108.26	-	-
Current Portion of Leases	23.6	17.21	17	13.29	9.28
Current Income Taxes Payable	-	0.63	0.66	0.94	1.2
Current Unearned Revenue	56.39	45.5	40.28	26.6	37.93
Other Current Liabilities	-	120.93	92.72	76.07	67.87
Total Current Liabilities	534.04	312.13	316.19	188.4	235
Long-Term Debt	66.29	184.04	123.97	129.71	-
Long-Term Leases	26.72	30.29	33.35	28.34	36.41
Long-Term Unearned Revenue	321.82	351.95	308.03	122.43	26.51
Other Long-Term Liabilities	47.28	48.88	48.38	47.7	-
Total Liabilities	996.16	927.28	829.92	516.58	297.92
Common Stock	2.8	2.8	2.8	2.8	2.8
Additional Paid-In Capital	-	1,401	1,401	1,401	1,401
Retained Earnings	-	-1,361	-1,233	-1,023	-812.5
Comprehensive Income & Other	154.5	46.25	34.42	20.95	11.17
Total Common Equity	157.3	88.93	205.06	400.94	601.98
Shareholders' Equity	157.3	88.93	205.06	400.94	601.98
Total Liabilities & Equity	1,153	1,016	1,035	917.52	899.9
Total Debt	326.74	311.59	282.57	171.34	46.43
Net Cash (Debt)	-217.48	-222.25	-109.23	-122.73	35.13
Net Cash Growth	-	-	-	-	-92.10%
Net Cash Per Share	-0.04	-0.05	-0.03	-0.03	0.01
Filing Date Shares Outstanding	7,303	4,124	4,124	4,124	4,124
Total Common Shares Outstanding	7,303	4,124	4,124	4,124	4,124
Working Capital	-99.74	53.65	26.02	12.72	12.77
Book Value Per Share	0.02	0.02	0.05	0.10	0.15
Tangible Book Value	61.05	88.93	205.06	400.94	601.98
Tangible Book Value Per Share	0.01	0.02	0.05	0.10	0.15
Buildings	-	198.29	198.21	117.92	117.92
Machinery	-	389.32	357.53	335.14	280.95
Construction In Progress	-	125.3	167.23	239.12	98.4
Leasehold Improvements	-	79.09	78.79	78.79	78.63

Source: S&P Global Market Intelligence. Standard template. Financial Sources.